Business Description
Veritas In Silico Inc
ISIN : JP3155340007
Total Employee Number:
19Description
Veritas In Silico Inc is engaged in discovery of mRNA-targeted small molecule and antisense oligonucleotide drugs. It has ibVIS platform that combines informatics (i) and experimental biology at Veritas In Silico (VIS) that will bring to fruition mRNA-targeted drugs. The company operates a pipeline-type business model, currently focuses on nucleic acid drugs.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.86 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | 16.46 | |||||
Beneish M-Score | -1.35 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -24.4 | |||||
3-Year EBITDA Growth Rate | -43.9 | |||||
3-Year EPS without NRI Growth Rate | -34.1 | |||||
3-Year FCF Growth Rate | -11.1 | |||||
3-Year Book Growth Rate | 4 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 37.73 | |||||
9-Day RSI | 43.11 | |||||
14-Day RSI | 45.62 | |||||
3-1 Month Momentum % | -16.77 | |||||
6-1 Month Momentum % | -13.81 | |||||
12-1 Month Momentum % | -39.32 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 7.79 | |||||
Quick Ratio | 7.74 | |||||
Cash Ratio | 7.57 | |||||
Days Sales Outstanding | 157.82 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -1 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Operating Margin % | -612.94 | |||||
Net Margin % | -972.62 | |||||
EBITDA Margin % | -597.39 | |||||
FCF Margin % | -890.85 | |||||
OCF Margin % | -806.64 | |||||
ROE % | -19.21 | |||||
ROA % | -18.21 | |||||
ROIC % | -370.37 | |||||
3-Year ROIIC % | 2754.1 | |||||
ROC (Joel Greenblatt) % | -1099.92 | |||||
ROCE % | -12.07 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 73.09 | |||||
PB Ratio | 1.78 | |||||
Price-to-Tangible-Book | 1.78 | |||||
EV-to-EBIT | -4.38 | |||||
EV-to-EBITDA | -4.49 | |||||
EV-to-Revenue | 26.85 | |||||
EV-to-FCF | -3.01 | |||||
| Price-to-Net-Current-Asset-Value | 1.8 | |||||
| Price-to-Net-Cash | 1.86 | |||||
Earnings Yield (Greenblatt) % | -22.83 | |||||
FCF Yield % | -12.19 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Veritas In Silico Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil 円) | 37.1 | ||
| EPS (TTM) (円) | -55.62 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 49.7 | ||
| 14-Day RSI | 45.62 | ||
| 14-Day ATR (円) | 16.551602 | ||
| 20-Day SMA (円) | 426.1 | ||
| 12-1 Month Momentum % | -39.32 | ||
| 52-Week Range (円) | 390 - 940 | ||
| Shares Outstanding (Mil) | 6.49 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Veritas In Silico Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Veritas In Silico Inc Stock Events
| Event | Date | Price (円) | ||
|---|---|---|---|---|
| No Event Data | ||||
Veritas In Silico Inc Frequently Asked Questions
What is Veritas In Silico Inc(TSE:130A)'s stock price today?
The current price of TSE:130A is 円418.00. The 52 week high of TSE:130A is 円940.00 and 52 week low is 円390.00.
When is next earnings date of Veritas In Silico Inc(TSE:130A)?
The next earnings date of Veritas In Silico Inc(TSE:130A) is .
Does Veritas In Silico Inc(TSE:130A) pay dividends? If so, how much?
Veritas In Silico Inc(TSE:130A) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Veritas In Silico Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers